Investing Profile

Corey Goodman

InvestorVCAngel
Managing Partner at venBio
venbio.com/corey.htmlSan Francisco, California
Photo of Corey Goodman, Managing Partner at venBio

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
venBio Managing Partner
$20.0M - $30.0M
$25.0M
16
CompanyStageDateRound SizeTotal Raised
FogPharma
Series EMar 2024$150M
Series DNov 2022$180M
Series CJan 2021$110M
$430M
Co-investors: Thilo Schroeder (Nextech Invest)
Insamo
SeedFeb 2024$12M
$12M
Co-investors: Matt Hershenson (Playground Global)
MindRhythm
SeedAug 2021$5M
$5M
Co-investors: Pierre Lamond (Eclipse Ventures), Kyle York
Tallac Therapeutics
Series ADec 2020$62M
$62M
Checkmate Pharmaceuticals
Series CJun 2020$85M
Series CDec 2018$22M
Series BJun 2017$27M
Series AAug 2015$20M
$150M
Co-investors: Ben Auspitz (F-Prime Capital Partners), Michael Powell (Omega Funds), Daniel Coley (Cofounders Capital)
ALX Oncology
Series CFeb 2020$110M
Convertible NoteMar 2017$25M
Series AMar 2015$36M
$170M
Co-investors: Jack Nielsen (Vivo Capital)
Queenly
Pre SeedOct 2019$800K
$8.8M
Co-investors: Connie Chan (Andreessen Horowitz), Daniel Ha (XX), Shayna Modarresi (Runway Growth Capital), Jeremy Fiance (The House Fund), Gustaf Alströmer (Y Combinator), Michael Seibel (Y Combinator), David Beisel (NextView Ventures), Eric Kwan (Locus Ventures), Manik Gupta, Jon Brelig, Jason Wang, James Park, Ralph Gootee
Good2Go, Inc
SeedSep 2017$7M
$7M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Bob Pavey (Morgenthaler Ventures), Shailesh Rao (BigSpring), Nancy Schoendorf (Mohr Davidow Ventures)
Managing Partner venBio PartnersPresent